Fried Michal, Wendler Jason P, Mutabingwa Theonest K, Duffy Patrick E
Seattle Biomedical Research Institute, Seattle, Washington 98109, USA.
Proteomics. 2004 Apr;4(4):1086-93. doi: 10.1002/pmic.200300666.
Surface proteins from Plasmodium falciparum are important malaria vaccine targets. However, the surface proteins previously identified are highly variant and difficult to study. We used tandem mass spectrometry to characterize the variant antigens (Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)) expressed on the surface of malaria-infected erythrocytes that bind to chondroitin sulfate A (CSA) in the placenta. Whereas PfEMP1 variants previously implicated as CSA ligands were detected, in unselected parasites four novel variants were detected in CSA-binding or placental parasites but not in unselected parasites. These novel PfEMP1 variants require further study to confirm whether they play a role in placental malaria.
恶性疟原虫的表面蛋白是重要的疟疾疫苗靶点。然而,先前鉴定出的表面蛋白高度可变,难以研究。我们使用串联质谱法来表征在感染疟疾的红细胞表面表达的、与胎盘硫酸软骨素A(CSA)结合的变异抗原(恶性疟原虫红细胞膜蛋白1(PfEMP1))。虽然检测到了先前被认为是CSA配体的PfEMP1变体,但在未经筛选的寄生虫中未检测到,而在与CSA结合的寄生虫或胎盘寄生虫中检测到了四种新变体。这些新的PfEMP1变体需要进一步研究,以确认它们是否在胎盘疟疾中起作用。